Product
Timolol
Aliases
Timolol 0.5%
11 clinical trials
10 indications
Indication
GlaucomaIndication
ocular hypertensionIndication
open-angle glaucomaIndication
Primary Open-Angle GlaucomaIndication
Primary Open-angle GlaucomaIndication
Chronic Diabetic Foot UlcersIndication
Diabetic Neuropathic UlcersIndication
Non Healing WoundIndication
Ocular HypertensionIndication
Infantile HemangiomaClinical trial
A Phase 2b Randomized, Double-masked, Active-controlled, Dose-response Study of the Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma (POAG) or Ocular HypertensionStatus: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
Randomized, Multicenter, Observer-Masked Study to Compare Safety/Efficacy of Nebivolol Suspension 0.5% or 1.0%, or Timolol Suspension 0.5% to Timolol Solution 0.5% in Participants With Primary Open Angle Glaucoma or Ocular HypertensionStatus: Completed, Estimated PCD: 2022-03-31
Clinical trial
A Phase 1/2a Assessment of WB007 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular HypertensionStatus: Completed, Estimated PCD: 2021-01-31
Clinical trial
A Non-inferiority in the Intraocular Pressure Decrease of the Preservative-free Ophthalmic Solution PRO-122 Versus Concomitant Therapy in Subjects With Uncontrolled Primary Open-angle GlaucomaStatus: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
Beta Adrenergic Antagonist For The Healing of Chronic Diabetic Foot UlcersStatus: Completed, Estimated PCD: 2023-12-01
Clinical trial
Comparison of the Effects of Latanoprost and Timolol on Aqueous Humor Dynamics in Ocular Hypertensive PatientsStatus: Terminated, Estimated PCD: 2008-10-01
Clinical trial
Aqueous Humor Dynamic Components That Determine Intraocular Pressure VarianceStatus: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile HemangiomasStatus: Recruiting, Estimated PCD: 2025-03-31
Clinical trial
Efficacy and Safety of add-on Topical Timolol in the Management of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-induced Paronychia: A Prospective Randomized Open-labelled TrialStatus: Recruiting, Estimated PCD: 2023-12-31
Clinical trial
Circadian Rhythms of Aqueous Humor Dynamics in HumansStatus: Completed, Estimated PCD: 2009-11-01
Clinical trial
Stop Retinal Ganglion Cell Dysfunction StudyStatus: Active (not recruiting), Estimated PCD: 2024-07-01